Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Director | $120K | May 1, 2024 | ||
ACLX | Arcellx, Inc. | Director | $0 | -$1.16M | -100% | May 28, 2024 |
CTNM | Contineum Therapeutics, Inc. | Director | May 24, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|